Distinct Effects of Saracatinib on Memory CD8+ T Cell Differentiation
The Journal of Immunology, 05/09/2012Takai S et al.
Vaccine plus saracatinib treatment showed better protection against tumor challenge. The immune–potentiating effects on CD8+ T cells by a low dose of saracatinib might afford better protection from pathogens or cancer when combined with vaccine.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.